You deserve tomorrow.

News

12/01/2022 Mayne Pharma adds a generic PROTOPIC to US portfolio

17/01/2022 Non-Executive Director appointment and retirement

 

For further news, refer to Company Announcements

Subscribe for email alerts to receive Mayne Pharma announcements released to the ASX